|Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humans|
D Serruto, T Spadafina, L Ciucchi, LA Lewis, S Ram, M Tontini, L Santini, ...
Proceedings of the National Academy of Sciences 107 (8), 3770-3775, 2010
|Neisseria meningitidis is structured in clades associated with restriction modification systems that modulate homologous recombination|
S Budroni, E Siena, JCD Hotopp, KL Seib, D Serruto, C Nofroni, ...
Proceedings of the National Academy of Sciences 108 (11), 4494-4499, 2011
|Vaccinology in the genome era|
CD Rinaudo, JL Telford, R Rappuoli, KL Seib
The Journal of clinical investigation 119 (9), 2515-2525, 2009
|Phasevarions mediate random switching of gene expression in pathogenic Neisseria|
YN Srikhanta, SJ Dowideit, JL Edwards, ML Falsetta, HJ Wu, OB Harrison, ...
PLoS Pathog 5 (4), e1000400, 2009
|Developing vaccines in the era of genomics: a decade of reverse vaccinology|
KL Seib, X Zhao, R Rappuoli
Clinical Microbiology and Infection 18, 109-116, 2012
|Transcriptome analysis of Neisseria meningitidis in human whole blood and mutagenesis studies identify virulence factors involved in blood survival|
H Echenique-Rivera, A Muzzi, E Del Tordello, KL Seib, P Francois, ...
PLoS Pathog 7 (5), e1002027, 2011
|Defenses against oxidative stress in Neisseria gonorrhoeae and Neisseria meningitidis: distinctive systems for different lifestyles|
KL Seib, HJ Tseng, AG McEwan, MA Apicella, MP Jennings
The Journal of infectious diseases 190 (1), 136-147, 2004
|Defenses against oxidative stress in Neisseria gonorrhoeae: a system tailored for a challenging environment|
KL Seib, HJ Wu, SP Kidd, MA Apicella, MP Jennings, AG McEwan
Microbiology and molecular biology reviews 70 (2), 344-361, 2006
|The key role of genomics in modern vaccine and drug design for emerging infectious diseases|
KL Seib, G Dougan, R Rappuoli
PLoS Genet 5 (10), e1000612, 2009
|Factor H-binding protein is important for meningococcal survival in human whole blood and serum and in the presence of the antimicrobial peptide LL-37|
KL Seib, D Serruto, I Delany, J Adu-Bobie, D Veggi, B Aricò, R Rappuoli, ...
Infection and immunity 77 (1), 292-299, 2009
|Characterization of the OxyR regulon of Neisseria gonorrhoeae|
KL Seib, HJ Wu, YN Srikhanta, JL Edwards, ML Falsetta, AJ Hamilton, ...
Molecular microbiology 63 (1), 54-68, 2007
|The RNA chaperone Hfq is involved in stress response and virulence in Neisseria meningitidis and is a pleiotropic regulator of protein expression|
L Fantappie, MM Metruccio, KL Seib, ...
Infect Immun 77, 1842-1853, 2009
|Vaccines, reverse vaccinology, and bacterial pathogenesis|
I Delany, R Rappuoli, KL Seib
Cold Spring Harbor perspectives in medicine 3 (5), a012476, 2013
|Pilin glycosylation in Neisseria meningitidis occurs by a similar pathway to wzy-dependent O-antigen biosynthesis in Escherichia coli|
PM Power, KL Seib, MP Jennings
Biochemical and biophysical research communications 347 (4), 904-908, 2006
|Characterization of diverse subvariants of the meningococcal factor H (fH) binding protein for their ability to bind fH, to mediate serum resistance, and to induce bactericidal …|
KL Seib, B Brunelli, B Brogioni, E Palumbo, S Bambini, A Muzzi, ...
Infection and immunity 79 (2), 970-981, 2011
|PerR controls Mn‐dependent resistance to oxidative stress in Neisseria gonorrhoeae|
HJ Wu, KL Seib, YN Srikhanta, SP Kidd, JL Edwards, TL Maguire, ...
Molecular microbiology 60 (2), 401-416, 2006
|OxyR tightly regulates catalase expression in Neisseria meningitidis through both repression and activation mechanisms|
R Ieva, D Roncarati, MME Metruccio, KL Seib, V Scarlato, I Delany
Molecular microbiology 70 (5), 1152-1165, 2008
|Is gonococcal disease preventable? The importance of understanding immunity and pathogenesis in vaccine development|
JL Edwards, MP Jennings, MA Apicella, KL Seib
Critical reviews in microbiology 42 (6), 928-941, 2016
|A Sco homologue plays a role in defence against oxidative stress in pathogenic Neisseria|
KL Seib, MP Jennings, AG McEwan
FEBS letters 546 (2-3), 411-415, 2003
|Phase variable restriction–modification systems in Moraxella catarrhalis|
KL Seib, IRA Peak, MP Jennings
FEMS Immunology & Medical Microbiology 32 (2), 159-165, 2002